Terrence C Kearney Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Terrence C Kearney.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Terrence C Kearney. Terrence C Kearney is Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Innoviva, Inc. ($THRX) and SVP, Finance and CFO in HOSPIRA INC ($HSP) and Director in ACCELERON PHARMA INC ($XLRN) and Director in AveXis, Inc. ($AVXS).
Latest Insider Trading Transactions of Terrence C Kearney
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, AVXS, HSP, THRX, VRTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 217.20 | 6,067 | 1,317,752 | 6,067 | |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | M | 30.17 | 7,500 | 226,275 | 0 | |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | M | 27.97 | 10,000 | 279,700 | 0 | |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | M | 28.37 | 20,000 | 567,400 | 0 | |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 120.57 | 913 | 110,080 | 5,127 | 6 K to 5.1 K (-15.12 %) |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 119.78 | 16,210 | 1,941,634 | 6,040 | 22.3 K to 6 K (-72.85 %) |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 119.11 | 18,177 | 2,165,062 | 22,250 | 40.4 K to 22.3 K (-44.96 %) |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 117.82 | 2,200 | 259,204 | 40,427 | 42.6 K to 40.4 K (-5.16 %) |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Buy | M | 30.17 | 7,500 | 226,275 | 42,627 | 35.1 K to 42.6 K (+21.35 %) |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Buy | M | 27.97 | 10,000 | 279,700 | 35,127 | 25.1 K to 35.1 K (+39.80 %) |
Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Buy | M | 28.37 | 20,000 | 567,400 | 25,127 | 5.1 K to 25.1 K (+390.09 %) |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 286.27 | 4,527 | 1,295,944 | 4,527 | |
Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,377 | 0 | 5,127 | 3.8 K to 5.1 K (+36.72 %) |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 2,381 | 0 | 10,811 | 8.4 K to 10.8 K (+28.24 %) |
Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,250 | 0 | 3,750 | 2.5 K to 3.8 K (+50.00 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,801 | 0 | 8,430 | 6.6 K to 8.4 K (+27.17 %) |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | D | 20.00 | 26,496 | 529,920 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Sell | D | 0.00 | 1,106 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
Mar 30 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.00 | 2,188 | 0 | 6,629 | 4.4 K to 6.6 K (+49.27 %) |
Jun 01 2017 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 30.17 | 7,500 | 226,275 | 7,500 | |
Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 93.51 | 7,073 | 661,396 | 7,073 | |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Grant | A | 0.01 | 2,941 | 29 | 4,441 | 1.5 K to 4.4 K (+196.07 %) |
Feb 12 2016 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | A | 20.00 | 8,385 | 167,700 | 8,385 | |
Feb 12 2016 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | A | 20.00 | 18,111 | 362,220 | 18,111 | |
Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | A | 127.54 | 20,000 | 2,550,800 | 20,000 | |
May 21 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 56.99 | 1,500 | 85,485 | 375 | |
May 21 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 56.99 | 1,500 | 85,485 | 1,500 | 0 to 1.5 K |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 59.55 | 20,000 | 1,191,000 | 0 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 53.85 | 20,000 | 1,077,000 | 0 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 56.99 | 28,125 | 1,602,844 | 1,875 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 133.63 | 2,300 | 307,349 | 0 | 2.3 K to 0 (-100.00 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 132.82 | 5,668 | 752,824 | 2,300 | 8 K to 2.3 K (-71.13 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 131.76 | 3,969 | 522,955 | 7,968 | 11.9 K to 8 K (-33.25 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 130.58 | 8,800 | 1,149,104 | 11,937 | 20.7 K to 11.9 K (-42.44 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 129.94 | 4,500 | 584,730 | 20,737 | 25.2 K to 20.7 K (-17.83 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 128.12 | 16,295 | 2,087,715 | 25,237 | 41.5 K to 25.2 K (-39.23 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 127.50 | 26,593 | 3,390,608 | 41,532 | 68.1 K to 41.5 K (-39.04 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 59.55 | 20,000 | 1,191,000 | 68,125 | 48.1 K to 68.1 K (+41.56 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 53.85 | 20,000 | 1,077,000 | 48,125 | 28.1 K to 48.1 K (+71.11 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 56.99 | 28,125 | 1,602,844 | 28,125 | 0 to 28.1 K |
Apr 27 2015 | THRX | Innoviva, Inc. | Kearney Terrence C | Director | Grant | A | 0.00 | 13,950 | 0 | 37,083 | 23.1 K to 37.1 K (+60.30 %) |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 33.79 | 3,408 | 115,156 | 0 | |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 33.79 | 1,105 | 37,338 | 0 | |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 33.79 | 1,016 | 34,331 | 0 | |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 36.20 | 9,600 | 347,563 | 0 | |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 34.26 | 2,761 | 94,589 | 0 | |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 34.26 | 4,221 | 144,607 | 0 | |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 34.26 | 3,992 | 136,762 | 0 | |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Sell | S | 41.25 | 23,650 | 975,473 | 26,465 | 50.1 K to 26.5 K (-47.19 %) |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Buy | M | 33.79 | 5,529 | 186,825 | 50,115 | 44.6 K to 50.1 K (+12.40 %) |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Buy | M | 36.20 | 9,600 | 347,563 | 44,586 | 35 K to 44.6 K (+27.44 %) |
Sep 13 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Buy | M | 34.26 | 10,974 | 375,958 | 34,986 | 24 K to 35 K (+45.70 %) |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | A | 39.26 | 10,033 | 393,896 | 10,033 | |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 23.96 | 13,134 | 314,626 | 3,389 | |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | A | 39.26 | 298 | 11,699 | 298 | |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 27.14 | 366 | 9,933 | 0 | |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | A | 39.26 | 10,689 | 419,650 | 10,689 | |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | M | 28.27 | 12,872 | 363,853 | 22,178 | |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Payment of Exercise | F | 39.26 | 21,020 | 825,245 | 24,012 | 45 K to 24 K (-46.68 %) |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Buy | M | 23.96 | 13,134 | 314,626 | 45,032 | 31.9 K to 45 K (+41.17 %) |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Buy | M | 27.14 | 366 | 9,933 | 31,898 | 31.5 K to 31.9 K (+1.16 %) |
Jun 16 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Buy | M | 28.27 | 12,872 | 363,853 | 31,532 | 18.7 K to 31.5 K (+68.98 %) |
May 11 2005 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | A | 32.47 | 70,000 | 2,272,900 | 70,000 | |
May 06 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | A | 26.50 | 90,000 | 2,385,000 | 90,000 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 28.27 | 3,563 | 100,715 | 349,376 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 28.27 | 35,050 | 990,758 | 345,813 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 29.36 | 19,632 | 576,417 | 310,763 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 22.89 | 4,428 | 101,372 | 291,131 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 22.89 | 72,799 | 1,666,609 | 286,703 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 36.94 | 2,744 | 101,370 | 213,904 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 36.94 | 59,037 | 2,180,980 | 211,160 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 36.20 | 9,600 | 347,563 | 152,123 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 35.09 | 7,722 | 270,997 | 142,523 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 34.26 | 3,992 | 136,762 | 134,801 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 34.26 | 4,221 | 144,607 | 130,809 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 34.26 | 2,761 | 94,589 | 126,588 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 31.31 | 3,194 | 100,004 | 123,827 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 31.31 | 43,142 | 1,350,772 | 120,633 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 27.14 | 366 | 9,933 | 77,491 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 27.14 | 3,163 | 85,845 | 77,125 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 22.47 | 4,449 | 99,951 | 73,962 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 29.28 | 3,416 | 100,010 | 69,513 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 29.28 | 19,751 | 578,250 | 66,097 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 23.96 | 4,173 | 99,965 | 46,346 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 23.96 | 16,523 | 395,810 | 42,173 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 18.90 | 5,288 | 99,936 | 25,650 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 16.00 | 2,335 | 37,371 | 20,362 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 14.15 | 8,142 | 115,181 | 18,027 | |
May 05 2004 | HSP | HOSPIRA INC | Kearney Terrence C | SVP, Finance and CF ... | Option Exercise | C | 12.67 | 9,885 | 125,246 | 9,885 |
Page: 1